Tag: CDSCO
Pradhan Mantri Bhartiya Janaushadhi Pariyojana Records ₹2,252.19 Crore in Sales for FY 2025–26, Saving Citizens ₹9,000 Crore
The Department of Pharmaceuticals announced that the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) achieved total sales of ₹2,252.19 crore in the financial year 2025–26. The widespread availability of quality...
Department of Pharmaceuticals Integrates ‘Pharma Sahi Daam’ and ‘Pharma Jan Samadhan’ into a Single Unified Platform
The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, has officially integrated two essential citizen services, the Pharma Sahi Daam price-finding tool and the Pharma Jan Samadhan grievance redressal system into a single,...
Eli Lilly to Acquire Merida Biosciences in $2.875B Deal to Advance Precision Immunology
Eli Lilly and Company has entered into a definitive agreement to acquire Merida Biosciences, Inc., a privately held biotechnology company developing precision antibody-based therapies...
Ambuja Neotia Healthcare Announces Investment to Set Up 120-Bed Woman and Child Hospital in Howrah
Ambuja Neotia Healthcare Venture Ltd (ANHVL) has unveiled plans to establish a 120-bed specialized woman and child care hospital in Howrah, West Bengal, committing an investment...
AbbVie Submits Regulatory Application to EMA for Subcutaneous Induction of SKYRIZI®️ in Crohn’s Disease
AbbVie announced the submission of a regulatory application to the European Medicines Agency (EMA) seeking approval for SKYRIZI® (risankizumab) for subcutaneous (SC) induction dosing...
FDA Approves Takeda’s First-in-Class Therapy MIMRYLO for Polycythemia Vera Following Robust Phase 3 Results
Takeda announced that the U.S. Food and Drug Administration (FDA) has approved MIMRYLO, a first-in-class therapy indicated for the treatment of polycythemia vera. Polycythemiavera is a rare, chronic...
